Internal Quality Management
SCOA’s clinical core of seasoned healthcare professionals is composed of SCOA shareholders, who provide extensive expertise in managed care, clinical research, end of life care and quality management.
These shareholders comprise the SCOA Utility Management / Quality Management Committee and are responsible for the following tasks:
- Development of clinical pathways within the National Comprehensive Cancer Network (NCCN) guidelines, including cost analysis.
- At present, there are three internally developed clinical pathways for cancers including lung cancer, colon cancer, and pancreatic cancer.
- Peer to peer case review if requested by a client medical director.
- Technology assessment of new chemotherapies and supportive care therapies.
- Assisting client medical directors with substantive cancer care issues including minimizing imaging costs, developing standards for end of life care, especially hospice care, palliative care and medico-legal issues, as well as efficiently measuring and managing inpatient days related to hematology and oncology.
- Working with group patient services representatives to address patient issues.
- Reviewing patient and referring physician satisfaction surveys with client medical leadership in order to develop physician and office staff effectiveness in customer care.